Physician profile
Soham G Sheth
NPI 1386835841
$6,791.95
in general payments reported to CMS, 2019-2025
59 companies · $1,141 in 2025
The $1,141 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $492 · 2020: $189 · 2021: $484 · 2022: $1,100 · 2023: $1,803 · 2024: $1,584 · 2025: $1,141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,335 · Consulting Fee: $150 · Education: $42.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,335.15 |
| Consulting Fee | $150.00 |
| Education | $42.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,021.24 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Biogen, INC. | $974.31 | 2019-2025 | Vumerity, Tysabri, Leqembi |
| Pfizer INC. | $310.19 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $245.57 | 2019-2025 | |
| Lundbeck LLC | $229.37 | 2021-2025 | Vyepti |
| Alexion Pharmaceuticals, INC. | $223.30 | 2019-2025 | Ultomiris |
| Sk Life Science, INC. | $212.66 | 2020-2025 | |
| Ucb, INC. | $201.77 | 2019-2024 | Briviact, Rystiggo |
| Teva Pharmaceuticals USA, INC. | $201.12 | 2022-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Harmony Biosciences LLC | $191.49 | 2020-2025 | Wakix |
| Genentech USA, INC. | $188.26 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Eisai INC. | $186.65 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $185.53 | 2019-2025 | |
| Emd Serono, INC. | $180.08 | 2019-2025 | |
| Amgen INC. | $161.30 | 2019-2025 | Aimovig, Uplizna |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soham Sheth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.